Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1986 1
1987 2
1988 3
1989 1
1990 2
1991 4
1992 2
1993 3
1995 2
1996 1
2001 1
2007 1
2014 4
2015 3
2016 4
2017 4
2018 1
2019 1
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Maertens JA, Rahav G, Lee DG, Ponce-de-León A, Ramírez Sánchez IC, Klimko N, Sonet A, Haider S, Diego Vélez J, Raad I, Koh LP, Karthaus M, Zhou J, Ben-Ami R, Motyl MR, Han S, Grandhi A, Waskin H; study investigators. Maertens JA, et al. Among authors: waskin h. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140-6736(21)00219-1. Lancet. 2021. PMID: 33549194 Clinical Trial.
Voriconazole pharmacogenetics - Authors' reply.
Maertens JA, Waskin HA, West RM, Shaw PM. Maertens JA, et al. Among authors: waskin ha. Lancet. 2021 Aug 14;398(10300):578-579. doi: 10.1016/S0140-6736(21)00874-6. Lancet. 2021. PMID: 34391493 No abstract available.
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Maertens JA, Rahav G, Lee DG, Haider S, Ramirez-Sanchez IC, Klimko N, Ponce-de-León A, Han S, Wrishko R, Winchell GA, Grandhi A, Waskin H; study investigators. Maertens JA, et al. Among authors: waskin h. Clin Drug Investig. 2023 Sep;43(9):681-690. doi: 10.1007/s40261-023-01282-7. Epub 2023 Sep 7. Clin Drug Investig. 2023. PMID: 37676612 Free PMC article. Clinical Trial.
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).
Sferra TJ, Merta T, Neely M, Murta de Oliveira C, Lassaletta A, Fortuny Guasch C, Dorr MB, Winchell G, Su FH, Perko S, Fernsler D, Waskin H, Holden SR. Sferra TJ, et al. Among authors: waskin h. J Pediatric Infect Dis Soc. 2023 Jun 30;12(6):334-341. doi: 10.1093/jpids/piad031. J Pediatric Infect Dis Soc. 2023. PMID: 37389891 Free PMC article. Clinical Trial.
Effects of Treatment with Azoles Are Overstated.
Vendetti N, Salas M, Waskin H, Mast TC. Vendetti N, et al. Among authors: waskin h. Am J Med. 2017 Aug;130(8):e367. doi: 10.1016/j.amjmed.2017.02.044. Am J Med. 2017. PMID: 28734383 No abstract available.
Severe African trypanosomiasis with spurious hypoglycemia.
Nieman RE, Kelly JJ, Waskin HA. Nieman RE, et al. Among authors: waskin ha. J Infect Dis. 1989 Feb;159(2):360-2. doi: 10.1093/infdis/159.2.360. J Infect Dis. 1989. PMID: 2915160 No abstract available.
Pentamidine and fatal hypoglycemia.
Sattler FR, Waskin H. Sattler FR, et al. Among authors: waskin h. Ann Intern Med. 1987 Nov;107(5):789-90. doi: 10.7326/0003-4819-107-5-789_2. Ann Intern Med. 1987. PMID: 3662308 No abstract available.
47 results